Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology


      Background/Aims: The significance of abnormal liver function tests in the absence of diagnostic serology is unclear. The aim of this study was to report liver biopsy findings in a large group of patients with unexplained abnormal liver biochemistry.
      Methods: Histological findings were examined in 354 patients who underwent liver biopsy to investigate abnormal liver function tests.
      Results: Six percent of patients had a normal liver biopsy while 26% were found to have some degree of fibrosis and 6% were cirrhotic. Thirty four and 32% of biopsies suggested non-alcoholic steatohepatits or fatty liver respectively. Other diagnoses included cryptogenic hepatitis, drug toxicity, primary and secondary biliary cirrhosis, autoimmune hepatits, alcohol-related liver disease, primary sclerosing cholangitis, haemochromatosis, amyloid and glycogen storage disease. Patient management was directly altered in 18% of patients due to liver biopsy findings and three families were entered into screening programmes for inheritable liver disease.
      Conclusions: The finding of abnormal liver function tests in the absence of diagnostic serology may indicate significant liver disease. Liver biopsy yields a range of liver diseases of diverse nature and extent. Liver diseases may be uncovered for which specific treatment is indicated.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Grant A.
        • Neuberger J.
        Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology.
        Gut. 1999; 45: IVI
        • Van Ness N.M.
        • Diehl A.M.
        Is liver biopsy useful in the evaluation of patients with elevated liver enzymes?.
        Ann Intern Med. 1989; 11: 473
        • Hay J.E.
        • Czaja A.J.
        • Rakela J.
        • Ludwig J.
        The nature of unexplained chronic aminotransferase elevation of a mild to moderate degree in asymptomatic patients.
        Hepatology. 1989; 9: 193
        • Mathiesen U.L.
        • Franzen L.E.
        • Fryden A.
        • Foberg U.
        • Bodemar G.
        The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients.
        Scand J Gastroenterol. 1999; 34: 85
        • Katkov W.N.
        • Friedman L.S.
        • Cody H.
        • et al.
        Elevated serum alanine aminotransferase in blood donors; the contribution of hepatitis C virus.
        Ann Intern Med. 1991; 115: 882-884
      1. International Autoimmune Hepatitis Group Report. J Hepatol 1999;31:929--938.

        • Hulcrantz R.
        • Glaumann G.
        • Lindberg G.
        • Son Nilsson L.H.
        Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransaminases.
        Scand J Gastroenterol. 1986; 21: 109
        • Daniel S.
        • Ben-Menachem T.
        • Vasudevan G.
        • Ma C.K.
        • Blumenkehl M.
        Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.
        Am J Gastroenterol. 1999; 94: 3010-3014
        • Goldstein N.S.
        • Kodali V.P.
        • Gordon S.C.
        Histological spectrum of cryptogenic chronic liver disease and comparison with chronic autoimmune and chronic type C hepatitis.
        Am J Clin Pathol. 1995; 104: 567
        • Nguyen B.N.
        • Flejou J.F.
        • Terris B.
        • Belghiti J.
        • Degott C.
        Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms.
        Am J Surg Pathol. 1999; 23: 1441
        • McCluggage W.G.
        • Sloan J.M.
        Hepatic granulomas in Northern Ireland: a 13 year review.
        Histopathology. 1994; 25: 219
        • Benhamou Y.
        • Bochet M.
        • Di Martino V.
        • Charlotte F.
        • Azria F.
        • Coutellier A.
        • et al.
        Liver fibrosis progression in human immunodeficency virus and hepatitis C coinfected patients. The Multiviric Group.
        Hepatology. 1999; 30: 1054
        • Badizadegan K.
        • Jonas M.M.
        • Ott M.J.
        • Nelson S.P.
        • Perez-Atayde A.P.
        Histopathology of the liver in children with chronic hepatits C viral infection.
        Hepatology. 1998; 28: 1416
        • Junge J.
        • Horn T.
        • Vyberg M.
        • Christoffersen P.
        • Svendsen L.B.
        The pattern of fibrosis in the acinar zone 3 areas in early alcoholic liver disease.
        J Hepatol. 1991; 12: 83
        • Shiffman M.L.
        • Hofmann C.M.
        • Contos M.J.
        • Luketic V.A.
        • Sanyal A.J.
        • Sterling R.K.
        • et al.
        A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatits C virus and persistent viremia.
        Gastroenterology. 1999; 117: 1164
        • Pratt D.S.
        • Kaplan M.M.
        Evaluation of abnormal liver-enzyme results in asymptomatic patients.
        N Engl J Med. 2000; 342: 1266-1271